Bookmark

Add to MyYahoo RSS

Avandia, Rosiglitazone News

News on Avandia, Rosiglitazone (generic) continually updated from thousands of sources around the net.

Yesterday | CiteULike

The dual peroxisome proliferator-activated receptor alpha/delta...

The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effects. We report here the efficacy and safety of GFT505, a novel liver-targeted peroxisome proliferator-activated receptor alpha/delta agonist, in the db/db mouse model of diabetes.

Comment?

Related Topix: Medicine, Diabetes, Health, Fasting

Monday | ASHP

FDA Considers Data Confidentiality for Diabetes Drugs

FDA is pondering the appropriateness of releasing interim clinical trial data on cardiovascular risks for diabetes medications and, potentially, reconsidering how critical the trials are in the first place. "We did hear calls for whether we need to be reevaluating whether we need to be doing these large outcomes studies for all diabetes agents, going forward," said John Jenkins, director of FDA's Office of New Drugs, during an August 11 public hearing.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Diabetes, Health

Tue Sep 09, 2014

CiteULike

DASH:a

A novel molecular dynamics analysis algorithm, DASH, is introduced in this paper. DASH has been developed to utilize the sequential nature of MD simulation data.

Comment?

Related Topix: Medicine

•••
•••
•••
•••
•••
•••
•••